The VA Medical Center in North Las Vegas says they are the first hospital in the region to offer a new kind of testing.
TD Cowen reinitiated coverage on Tempus AI Inc (NASDAQ:TEM) with a Buy rating, increasing the price target to $74 from a previous target. The stock, currently trading at $61.85, has shown remarkable ...
Ageing backwards is a desire many nurture. For millionaire entrepreneur and founder of Blueprint, Bryan Johnson, it’s an obsession that makes them go to great lengths. It is perhaps this ...
While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...
A set of Colorado Senators are demanding extra oversight of the Colorado Bureau of Investigation after discoveries of 500-day ...
We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.
Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...
The San Jose Police Department is hoping to generate new leads in sexual assault cold cases by resubmitting hundreds of rape ...
You can also find out if the mallards you’re shooting are truly wild birds with a simple DNA test. Here's how. If you haven’t ...
A new round of genetic seafood testing conducted for a state advisory panel detected foreign shrimp that was falsely ...
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Shares of genetic testing company Illumina and Calvin Klein-owner PVH Corp fell on Tuesday after China placed the two ...